Lupin has been reportedly looking to demerge its API business, Glenmark Pharma is looking to sell Glenmark Life Sciences as well. Why? Forbes India explains
The vertical contributed around 6 percent—about Rs 990 crore—of the total sales of the firm, as per the report; Image: Shutterstock